Kay Warnott Email

VP, Clinical Operations and Regulatory Affairs . InSitu Biologics

Current Roles

Employees:
15
Revenue:
$3M
About
InSitu Biologics, LLC is an emerging biotech company focusing on development of new and proprietary treatments using its Matrixâ„¢ BioHydrogel. Their lead product, AnestaGelâ„¢, is a long-lasting and long-acting non-opiate painkiller, targeted for use in peri-operative regional pain management. AnestaGelâ„¢ uses a novel approach to delivering sustained-released analgesics into the target tissue via the Matrixâ„¢ BioHydrogel platform, which is a tunable, biocompatible, and pH neutral platform. This allows AnestaGelâ„¢ to provide target site-specific, non-migratory placement, a flexible and high dose drug-load reservoir capacity, and a tunable and predictable pharmacological effect.
InSitu Biologics Address
2155 Woodlane Drive
Woodbury, MN
United States
InSitu Biologics Email

Past Companies

InSitu Biologics, Inc.Vice President, Clinical Operations and Regulatory Affairs
Clinical Research ConsultantExecutive Director
Sollis TherapeuticsExecutive Director, Clinical Research

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.